Core Prescribing Solutions published a full article comparing Semaglutide and Tirzepatide in weight-management pathways.
Public source
Publisher name
Public post
💉 Semaglutide vs Tirzepatide — what are the key differences? Both medicines are used within weight-management pathways, but they are not the same. Semaglutide acts on G…
Company
Core Prescribing Solutions
"Your Professional & Trusted Partner"
- Industry
- Medical Practices
- Location
- Bradford, GB
- Company size
- 51–200 employees
About Core Prescribing Solutions
Core Prescribing Solutions is an award-winning healthcare organisation with more than 25 years of combined experience across the NHS, primary care, clinical pharmacy and health informatics. We work closely with GP practices, PCNs and wider NHS partners to reduce workload pressures, strengthen prescribing safety and improve patient outcomes. Our team delivers fully managed clinical pharmacist and pharmacy technician support that fits the needs of each practice. This includes structured medication reviews, medicines optimisation, long-term condition management, repeat prescription processing, acute workflow support and clinical audits. We also help practices prepare for CQC inspections, improve governance, and streamline day-to-day systems so teams can focus on patient care. We use real-world data and practical insights to create smarter ways of working. Whether it’s redesigning prescription flow, supporting ARRS workforce management, or improving digital processes, our aim is simple: better outcomes for patients, better efficiency for practices and long-term value for the NHS.
See moreLatest activity
Latest activity from Core Prescribing Solutions
9 signals
Research & Knowledge
Core Prescribing Solutions reported that nearly 250,000 young people have received a MenB vaccine since the catch-up campaign began in July, requiring two doses for full protection.
Research & Knowledge
Core Prescribing Solutions noted that NICE has updated its psychosis and schizophrenia guideline, clarifying antipsychotic medication terminology.
Operations & Supply
Core Prescribing Solutions highlighted that active Serious Shortage Protocols remain in place for Creon, Estradot patches, and Ramipril 1.25mg capsules.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
VitalCore Health
VitalCore Health published a 2026 JAMA Surgery analysis showing that among patients eligible for metabolic and bariatric surgery, use of surgery declined 46.4% from 2022 to 2025 while prescriptions for semaglutide and tirzepatide rose dramatically over the same period.
Research & Knowledge
IQDoctor
IQDoctor published a contribution exploring emerging research into the myostatin-activin axis and its potential role in preserving lean muscle during GLP-1-supported weight loss by Life Science Daily News.
Research & Knowledge
Lanserhof at The Arts Club
Lanserhof at The Arts Club published a study by Neetha Lobo, Nutritional Therapist and Functional Health Coach at the UK showing widespread nutritional shortfalls among GLP-1 users.
Research & Knowledge
Zyndio
Zyndio published a recent trial combining GLP-1 therapy with resistance training showing participants retained 92% of their lean mass while losing significant body fat.
Research & Knowledge
Rachel Scheer Nutrition